A dose-dependent decrease in the fraction of cases harboring M6P/IGF2R mutations in hepatocellular carcinomas from...

Area of Science:

• Oncology
• Radiation Oncology
• Molecular Biology

Background:

• Atomic bomb survivors exhibit a heightened risk for hepatocellular carcinoma (HCC).
• The underlying molecular mechanisms driving radiation-induced HCC remain largely unclear.
• Previous research indicated a dose-dependent increase in HCCs with TP53 mutations in survivors.

Purpose of the Study:

• To investigate the role of M6P/IGF2R mutations in radiation-induced HCC.
• To explore the relationship between radiation dose and mutations in the 3 -untranslated region (3 UTR) of M6P/IGF2R.
• To elucidate independent molecular pathways in HCC development influenced by radiation exposure.

Main Methods:

• Analysis of HCC samples from atomic bomb survivors.
• Mutation frequency analysis of TP53 and M6P/IGF2R 3 UTR.
• Statistical evaluation of mutation frequencies in relation to radiation dose.

Main Results:

• A radiation dose-dependent decrease in M6P/IGF2R 3 UTR mutations was observed (P = 0.0091).
• This suggests negative selection against cells with M6P/IGF2R 3 UTR mutations under radiation exposure.
• TP53 and M6P/IGF2R 3 UTR mutations were largely mutually exclusive, indicating distinct oncogenic pathways.

Conclusions:

• Radiation exposure favors TP53 mutations over M6P/IGF2R mutations in HCC development.
• The findings suggest distinct genotypic profiles for radiation-induced versus background HCCs.
• This could enable the differentiation of radiation-attributable cancers from other etiologies.